2019 American Society of Clinical Oncology Annual Meeting Coverage
Every June, the American Society of Clinical Oncology Annual Meeting brings together clinicians, researchers, and advocates to discuss the latest cancer study results. We’re proud to present our coverage below.
Research News:
Experimental Margetuximab May Help Treat Certain HER2-Positive Metastatic Breast Cancers
Can Treatment Regimens Before Surgery for Early-Stage HER2-Positive Breast Cancer Omit Chemotherapy?
Podcast Episodes:
Top Metastatic Breast Cancer Research at ASCO 2019
Maura Dickler, M.D.
Women Don't Need Reminders to Take Aromatase Inhibitors, They Need Better Treatments for Side Effects
Dawn Hershman, M.D., MS
ASCO 2019: The BWEL Study: Diet and Exercise in Women Diagnosed With Breast Cancer
Jennifer Ligibel, M.D.
ASCO 2019: Right to Try Legislation and Why Clinical Trial Entry Criteria Need to Change
Kelly Shanahan, M.D., independent patient advocate
ASCO 2019: Diet, Exercise, and Breast Cancer Outcomes
Karen Basen-Engquist, MPH, Ph.D.
Heard in the Halls Mini Episodes:
Can a Low-Fat Diet Reduce the Risk of Dying From Breast Cancer? — Heard in the Halls: Voices From the 2019 American Society of Clinical Oncology Annual Meeting
Rowan Chlebowski, M.D., Ph.D.
Live by Living — Heard in the Halls: Voices From the 2019 American Society of Clinical Oncology Annual Meeting
Dan Miller, founder of Live by Living
Metabolite Markers — Heard in the Halls: Voices From the 2019 American Society of Clinical Oncology Annual Meeting
Elizabeth O'Day, Ph.D., CEO and founder of Olaris Therapeutics
Can we help guide you?
Create a profile for better recommendations
-
Tamoxifen (Brand Names: Nolvadex, Soltamox)
Tamoxifen is the oldest and most-prescribed selective estrogen receptor modulator (SERM)....
-
Breast Cancer Stages
The stage of a breast cancer is determined by the cancer’s characteristics, such as how large it...
-
Breast Self-Exam
Breast self-exam, or regularly examining your breasts on your own, can be an important way to...
